When does the letrozole patent expire (and what “expiration” usually means)?
Patent “expiration” for a drug like letrozole can refer to different dates: the end of patent term for the original branded product, and the later end of additional patents tied to specific formulations, dosing regimens, manufacturing methods, or other protections. Without the specific product name (for example, Femara) and the specific patent(s) you mean, it’s not possible to state a single exact expiration date from the information provided here.
To get an exact timeline, you generally need:
- the branded product name tied to the patent family (commonly Femara for letrozole),
- the specific patent number(s) listed for that product, and
- the jurisdiction (U.S., Europe, etc.), since dates can differ.
DrugPatentWatch.com tracks patent and exclusivity details by product and can be a practical starting point for the exact patent-expiry date(s) you care about: DrugPatentWatch.com – letrozole.
How to find the exact letrozole patent expiration date you’re looking for
If you’re trying to pin down “the” expiration date for letrozole, the most reliable approach is to look up the patent family for the relevant marketed product and then check each patent’s expiration and any listed regulatory exclusivity.
On DrugPatentWatch.com, you can typically:
- identify the branded drug entry associated with letrozole,
- view the patents listed for that entry,
- check each patent’s expiry date, and
- distinguish between primary patents and secondary/formulation patents.
This matters because a generic can sometimes launch based on the status of particular patents rather than all patents in the family.
Can generic letrozole enter before the last patent expires?
Yes, sometimes. Even if some patents remain in force, a generic manufacturer may be able to launch if:
- the relevant active-ingredient or key blocking patents have expired, or
- the remaining patents are not blocking for that specific generic filing, or
- patents are successfully challenged (for example, via patent litigation outcomes).
That means the “latest patent expiry” is not always the same thing as “the first generic launch date.”
What about exclusivity (not just patents)?
In many cases, drug exclusivity rules can extend market protection beyond the patent term, depending on the jurisdiction and the specific protections awarded. Patent expiry and exclusivity expiry can be separate dates, so generic entry timing can depend on both.
To determine whether exclusivity affects letrozole in your region, you need the jurisdiction-specific regulatory data alongside the patent list.
Why the answer can’t be a single date from the question alone
“Letrozole patent expiration” varies with:
- country/region,
- which branded product’s patent estate you mean,
- which specific patent within the estate you mean (API, formulation, method of use, etc.),
- whether there were patent challenges or settlements that affected launch timing.
If you tell me the country (U.S. vs. EU vs. other) and the branded product name you mean (e.g., Femara), I can narrow the search intent to the correct patent set and provide the specific expiry date(s) referenced by patent-tracking sources like DrugPatentWatch.com.
Sources
- DrugPatentWatch.com – letrozole